Lecithin cholesterol acyltransferase deficiency

From WikiMD's WELLNESSPEDIA

(Redirected from LCATA deficiency)


Lecithin–cholesterol acyltransferase deficiency
Synonyms LCAT deficiency
Pronounce N/A
Specialty N/A
Symptoms Corneal opacities, anemia, kidney failure
Complications Renal failure, cardiovascular disease
Onset Childhood or early adulthood
Duration Lifelong
Types N/A
Causes Genetic mutation in the LCAT gene
Risks Family history of the condition
Diagnosis Blood test, genetic testing
Differential diagnosis Fish-eye disease, familial hypercholesterolemia
Prevention N/A
Treatment Symptomatic treatment, kidney transplant
Medication None specific
Prognosis Variable, depends on severity and management
Frequency Rare
Deaths N/A


Lecithin cholesterol acyltransferase deficiency (LCAT deficiency) is a rare genetic disorder characterized by the body's inability to properly metabolize certain fats (lipids) in the blood. The condition is caused by mutations in the LCAT gene and is inherited in an autosomal recessive manner.

Symptoms[edit]

The symptoms of LCAT deficiency can vary greatly from person to person. Some affected individuals may have no symptoms (asymptomatic) while others may develop serious complications. The most common symptoms include:

Causes[edit]

LCAT deficiency is caused by mutations in the LCAT gene. This gene provides instructions for making an enzyme called lecithin cholesterol acyltransferase, which is found in the blood and is involved in the metabolism of lipids. Mutations in the LCAT gene reduce or eliminate the activity of this enzyme, leading to the characteristic features of LCAT deficiency.

Diagnosis[edit]

The diagnosis of LCAT deficiency is based on a clinical evaluation, detailed patient history, and specialized laboratory testing. Genetic testing can confirm a diagnosis.

Treatment[edit]

There is currently no cure for LCAT deficiency. Treatment is directed toward the specific symptoms that are apparent in each individual. For example, individuals with kidney disease may require dialysis or a kidney transplant.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.